Abstract
Alan B. Scott selected, researched and developed Type A Botulinum toxin for clinical use in ophthalmology. This unique drug has proved invaluable for treatment of a number of conditions which are difficult to treat in ophthalmology and in a variety of other disciplines. The indications, methods and problems of its use are described and the results of treatment of 133 patients are discussed. Up to December 1986 over 13 000 patients have been treated in a multicentre international trial without significant complications. Copyright © 1988, Wiley Blackwell. All rights reserved
Author supplied keywords
Cite
CITATION STYLE
DUNLOP, D., PITTAR, G., & DUNLOP, C. (1988). BOTULINUM TOXIN IN OPHTHALMOLOGY. Australian and New Zealand Journal of Ophthalmology, 16(1), 15–20. https://doi.org/10.1111/j.1442-9071.1988.tb01194.x
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.
